Pseudomyxoma peritonei: natural history and treatment

References

• Sugarbaker PH. (1996). Pseudomyxoma peritonei. Cancer Treat Res 81:105–19.
   PubMedGoogle Scholar
• Moran BJ, Cecil TD. (2003). The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am 12:585–603.
   PubMedGoogle Scholar
• Weaver CH. (1937). Mucocele of appendix with pseudomucinous degeneration. Am J Surg 36:523–6.
   Google Scholar
• Werth R. (1884). Klinische und anatomische Untersuchungen zur Lehre von den Bauchgeschwülsten und der Laparatomie. Arch Für Gynäkol 24:100–18.
   Google Scholar
• Baratti D, Kusamura S, Milione M, et al. (2016). Pseudomyxoma peritonei of extra-appendiceal origin: a comparative study. Ann Surg Oncol 23:4222–30.
   PubMed Web of Science ®Google Scholar
• Castle OL. (1915). Cystic dilation of the vermiform appendix. Ann Surg 61:582–8.
   PubMedGoogle Scholar
• Complete cytoreduction for pseudomyxoma peritonei (Sugarbaker technique). Guidance and guidelines. NICE [Internet]. Available from: https://www.nice.org.uk/guidance/ipg56 [last accessed 24 Nov 2016].
   Google Scholar
• Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA. (2008). Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol 34:196–201.
   PubMed Web of Science ®Google Scholar
• Dayal S, Taflampas P, Riss S, et al. (2013). Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved. Dis Colon Rectum 56:1366–72.
   PubMed Web of Science ®Google Scholar
• Behling H. (1967). Mucocele of the appendix and jelly-belly. Minn Med 50:1109–12.
   PubMedGoogle Scholar
• Sugarbaker PH. (1994). Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon. Ann Surg 219:109–11.
   PubMed Web of Science ®Google Scholar
• Pestieau SR, Esquivel J, Sugarbaker PH. (2000). Pleural extension of mucinous tumor in patients with pseudomyxoma peritonei syndrome. Ann Surg Oncol 7:199–203.
   PubMed Web of Science ®Google Scholar
• Järvinen P, Lepistö A. (2010). Clinical presentation of pseudomyxoma peritonei. Scand J Surg 99:213–16.
   PubMed Web of Science ®Google Scholar
• Chuaqui RF, Zhuang Z, Emmert-Buck MR, et al. (1996). Genetic analysis of synchronous mucinous tumors of the ovary and appendix. Hum Pathol 27:165–71.
   PubMed Web of Science ®Google Scholar
• Guerrieri C, Frånlund B, Fristedt S, et al. (1997). Mucinous tumors of the vermiform appendix and ovary, and pseudomyxoma peritonei: histogenetic implications of cytokeratin 7 expression. Hum Pathol 28:1039–45.
   PubMed Web of Science ®Google Scholar
• Szych C, Staebler A, Connolly DC, et al. (1999). Molecular genetic evidence supporting the clonality and appendiceal origin of pseudomyxoma peritonei in women. Am J Pathol 154:1849–55.
   PubMed Web of Science ®Google Scholar
• Ronnett BM, Shmookler BM, Diener-West M, et al. (1997). Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Int J Gynecol Pathol 16:1–9.
   PubMed Web of Science ®Google Scholar
• Lee SE, Jang J-Y, Yang SH, Kim S-W. (2007). Intraductal papillary mucinous carcinoma with atypical manifestations: report of two cases. World J Gastroenterol 13:1622–5.
   PubMed Web of Science ®Google Scholar
• Smeenk RM, Bex A, Verwaal VJ, et al. (2006). Pseudomyxoma peritonei and the urinary tract: involvement and treatment related complications. J Surg Oncol 93:20–3.
   PubMed Web of Science ®Google Scholar
• Ronnett BM, Zahn CM, Kurman RJ, et al. (1995). Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to “pseudomyxoma peritonei”. Am J Surg Pathol 19:1390–408.
   PubMed Web of Science ®Google Scholar
• Bradley RF, Stewart JH, Russell GB, et al. (2006). Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol 30:551–9.
   PubMed Web of Science ®Google Scholar
• Carr NJ, Sobin LH. (2010). Adenocarcinoma of the appendix. In: Bosman FT, Carneiro F, Hruban RH, et al., eds. WHO classification of tumors of the digestive system. Lyon: IARC, 12212–15.
   Google Scholar
• Carr NJ, Cecil TD, Mohamed F, et al. (2016). A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the Peritoneal Surface Oncology Group International (PSOGI) modified Delphi process. Am J Surg Pathol 40:14–26.
   PubMed Web of Science ®Google Scholar
• Esquivel J, Sugarbaker PH. (2000). Clinical presentation of the pseudomyxoma peritonei syndrome. Br J Surg 87:1414–18.
   PubMed Web of Science ®Google Scholar
• Glaysher M, Gordon-Dixon A, Chandrakumaran K, et al. (2014). Pseudomyxoma peritonei of appendiceal origin: mode of presentation in the modern era. Colorectal Dis 16:53.
   Google Scholar
• Murphy EMA, Farquharson SM, Moran BJ. (2006). Management of an unexpected appendiceal neoplasm. Br J Surg 93:783–92.
   PubMed Web of Science ®Google Scholar
• Sulkin TVC, O’Neill H, Amin AI, Moran B. (2002). CT in pseudomyxoma peritonei: a review of 17 cases. Clin Radiol 57:608–13.
   PubMed Web of Science ®Google Scholar
• Jacquet P, Jelinek JS, Chang D, et al. (1995). Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. J Am Coll Surg 181:530–8.
   PubMed Web of Science ®Google Scholar
• Cotton F, Pellet O, Gilly F-N, et al. (2006). MRI evaluation of bulky tumor masses in the mesentery and bladder involvement in peritoneal carcinomatosis. Eur J Surg Oncol 32:1212–16.
   PubMed Web of Science ®Google Scholar
• Tirumani SH, Fraser-Hill M, Auer R, et al. (2013). Mucinous neoplasms of the appendix: a current comprehensive clinicopathologic and imaging review. Cancer Imaging 13:14–25.
   PubMed Web of Science ®Google Scholar
• Low RN, Barone RM, Gurney JM, Muller WD. (2008). Mucinous appendiceal neoplasms: preoperative MR staging and classification compared with surgical and histopathologic findings. Am J Roentgenol 190:656–65.
   PubMed Web of Science ®Google Scholar
• Low RN, Sebrechts CP, Barone RM, Muller W. (2009). Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings-a feasibility study. Am J Roentgenol 193:461–70.
   PubMed Web of Science ®Google Scholar
• Menassel B, Duclos A, Passot G, et al. (2016). Preoperative CT and MRI prediction of non-resectability in patients treated for pseudomyxoma peritonei from mucinous appendiceal neoplasms. Eur J Surg Oncol 42:558–66.
   PubMed Web of Science ®Google Scholar
• Moran BJ, Cecil TD. (2014). Treatment of surgically resectable colorectal peritoneal metastases. Br J Surg 101:5–7.
   PubMed Web of Science ®Google Scholar
• Passot G, Glehen O, Pellet O, et al. (2010). Pseudomyxoma peritonei: role of 18F-FDG PET in preoperative evaluation of pathological grade and potential for complete cytoreduction. Eur J Surg Oncol 36:315–23.
   PubMed Web of Science ®Google Scholar
• Wagner PL, Austin F, Sathaiah M, et al. (2013). Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin. Ann Surg Oncol 20:506–14.
   PubMed Web of Science ®Google Scholar
• Taflampas P, Dayal S, Chandrakumaran K, et al. (2014). Pre-operative tumour marker status predicts recurrence and survival after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal pseudomyxoma peritonei: analysis of 519 patients. Eur J Surg Oncol 40:515–20.
   PubMed Web of Science ®Google Scholar
• Alexander-Sefre F, Chandrakumaran K, Banerjee S, et al. (2005). Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence. Colorectal Dis 7:382–6.
   PubMed Web of Science ®Google Scholar
• Baratti D, Kusamura S, Martinetti A, et al. (2007). Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 14:2300–8.
   PubMed Web of Science ®Google Scholar
• Carmignani CP, Hampton R, Sugarbaker CE, et al. (2004). Utility of CEA and CA 19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix. J Surg Oncol 87:162–6.
   PubMed Web of Science ®Google Scholar
• van Ruth S, Hart AAM, Bonfrer JMG, et al. (2002). Prognostic value of baseline and serial carcinoembryonic antigen and carbohydrate antigen 19.9 measurements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 9:961–7.
   PubMed Web of Science ®Google Scholar
• Koh J-L, Liauw W, Chua T, Morris DL. (2013). Carbohydrate antigen 19-9 (CA 19-9) is an independent prognostic indicator in pseudomyxoma peritonei post cytoreductive surgery and perioperative intraperitoneal chemotherapy. J Gastrointest Oncol 4:173–81.
   PubMedGoogle Scholar
• Kusamura S, Baratti D, Hutanu I, et al.. The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction [Internet]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/?term=Eur+J+Surg+Oncol.+2015+Aug%3B41(8)%3A1097-105 [last accessed 06 Feb 2017].
   Google Scholar
• Kusamura S, Hutanu I, Baratti D, Deraco M. (2013). Circulating tumor markers: predictors of incomplete cytoreduction and powerful determinants of outcome in pseudomyxoma peritonei. J Surg Oncol 108:1–8.
   PubMed Web of Science ®Google Scholar
• Di Fabio F, Aston W, Mohamed F, et al. (2015). Elevated tumour markers are normalized in most patients with pseudomyxoma peritonei 7 days after complete tumour removal. Colorectal Dis 17:698–703.
   PubMed Web of Science ®Google Scholar
• Youssef H, Newman C, Chandrakumaran K, et al. (2011). Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin. Dis Colon Rectum 54:293–9.
   PubMed Web of Science ®Google Scholar
• Moran B, Baratti D, Yan TD, et al. (2008). Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei). J Surg Oncol 98:277–82.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH, Chang D. (1999). Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6:727–31.
   PubMed Web of Science ®Google Scholar
• Jacquet P, Sugarbaker PH. (1996). Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359–74.
   PubMedGoogle Scholar
• Chua TC, Moran BJ, Sugarbaker PH, et al. (2012). Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30:2449–56.
   PubMed Web of Science ®Google Scholar
• Yan TD, Bijelic L, Sugarbaker PH. (2007). Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms. Ann Surg Oncol 14:2289–99.
   PubMed Web of Science ®Google Scholar
• Hermanek P, Wittekind C. (1994). The pathologist and the residual tumor (R) classification. Pathol Res Pract 190:115–23.
   PubMed Web of Science ®Google Scholar
• Witkamp AJ, de Bree E, Kaag MM, et al. (2001). Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer 37:979–84.
   PubMed Web of Science ®Google Scholar
• Kajitani T. (1981). The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification. Jpn J Surg 11:127–39.
   PubMedGoogle Scholar
• Taflampas P, Moran BJ. (2013). Extraperitoneal resection of the right colon for locally advanced colon cancer. Colorectal Dis 15:e56–9.
   PubMed Web of Science ®Google Scholar
• Di Fabio F, Mehta A, Chandrakumaran K, et al. (2016). Advanced pseudomyxoma peritonei requiring gastrectomy to achieve complete cytoreduction results in good long-term oncologic outcomes. Ann Surg Oncol 23:4316–21.
   PubMed Web of Science ®Google Scholar
• Blackham AU, Swett K, Eng C, et al. (2014). Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol 109:740–5.
   PubMed Web of Science ®Google Scholar
• Stocchi L, Wolff BG, Larson DR, Harrington JR. (2003). Surgical treatment of appendiceal mucocele. Arch Surg 138:585–90.
   PubMedGoogle Scholar
• Gough DB, Donohue JH, Schutt AJ, et al. (1994). Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg 219:112–19.
   PubMed Web of Science ®Google Scholar
• Nitecki SS, Wolff BG, Schlinkert R, Sarr MG. (1994). The natural history of surgically treated primary adenocarcinoma of the appendix. Ann Surg 219:51–7.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. (1989). Surgical treatment of peritoneal carcinomatosis: 1988 Du Pont lecture. Can J Surg 32:164–70.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. (1995). Peritonectomy procedures. Ann Surg 221:29–42.
   PubMed Web of Science ®Google Scholar
• Omohwo C, Nieroda CA, Studeman KD, et al. (2009). Complete cytoreduction offers longterm survival in patients with peritoneal carcinomatosis from appendiceal tumors of unfavorable histology. J Am Coll Surg 209:308–12.
   PubMed Web of Science ®Google Scholar
• Elias D, Gilly F, Quenet F, et al. (2010). Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol 36:456–62.
   PubMed Web of Science ®Google Scholar
• Spiliotis J, Efstathiou E, Halkia E, et al. (2012). The influence of tumor cell entrapment phenomenon on the natural history of pseudomyxoma peritonei syndrome. Hepatogastroenterology 59:705–8.
   PubMedGoogle Scholar
• McBride K, McFadden D, Osler T. (2013). Improved survival of patients with pseudomyxoma peritonei receiving intraperitoneal chemotherapy with cytoreductive surgery: a systematic review and meta-analysis. J Surg Res 183:246–52.
   PubMed Web of Science ®Google Scholar
• Ansari N, Chandrakumaran K, Dayal S, et al. (2016). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1000 patients with perforated appendiceal epithelial tumours. Eur J Surg Oncol 42:1035–41.
   PubMed Web of Science ®Google Scholar